Search Results

Displaying Results 76-100 of 182 "'BK'"

Mar 25, 2026, 10:53 ET Axi lance le podcast « The Strategy Room » animé par Kathy Lien

le lancement de The Strategy Room by Axi Select, une nouvelle série de podcasts animée par la célèbre stratège des devises et directrice générale de BK Forex, Kathy Lien. La série est conçue pour fournir aux traders un accès direct aux stratégies, à la réflexion et aux approches de gestion des risques

More news about: AxiTrader


Mar 25, 2026, 09:23 ET Axi lanza el podcast "The Strategy Room" presentado por Kathy Lien

lanzamiento de The Strategy Room de Axi Select, una nueva serie de podcasts presentada por la reconocida estratega de divisas y directora general de BK Forex, Kathy Lien. La serie está diseñada para brindar a los operadores acceso directo a las estrategias, el pensamiento y los enfoques de gestión de

More news about: AxiTrader


Mar 25, 2026, 09:00 ET Axi Launches "The Strategy Room" Podcast Hosted by Kathy Lien

Global trading firm Axi today announced the launch of The Strategy Room by Axi Select, a new podcast series hosted by renowned currency strategist and BK Forex Managing Director Kathy Lien. The series is designed to provide traders with direct access to the strategies, thinking, and risk management approaches

More news about: AxiTrader


Mar 25, 2026, 09:00 ET Axi Launches "The Strategy Room" Podcast Hosted by Kathy Lien

Global trading firm Axi today announced the launch of The Strategy Room by Axi Select, a new podcast series hosted by renowned currency strategist and BK Forex Managing Director Kathy Lien. The series is designed to provide traders with direct access to the strategies, thinking, and risk management approaches

More news about: AxiTrader


Mar 23, 2026, 09:00 ET Genpact Named as One of the 2026 World's Most Ethical Companies® by Ethisphere for the Eighth Time

and human-validated environments, trust, accountability, and strong governance become essential to sustaining innovation at scale," said Balkrishan "BK" Kalra, President and Chief Executive Officer, Genpact. "This recognition reflects our long‑standing commitment to embedding integrity into our culture

More news about: Genpact


Mar 17, 2026, 07:35 ET Knight Therapeutics anuncia submissão regulatória suplementar de MINJUVI® (tafasitamabe) para linfoma folicular na Argentina e no México

2012;157:188-196.Freedman A, Jacobsen E. Follicular lymphoma: 2020 update on diagnosis and management. Am J Hematol 2020;95:316-327.Link BK, Maurer MJ, Nowakowski GS, et al. Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University

More news about: Knight Therapeutics Inc.


Mar 17, 2026, 07:35 ET Knight Therapeutics anuncia la presentación regulatoria complementaria de MINJUVI® (tafasitamab) para linfoma folicular en Argentina y México

2012;157:188-196.Freedman A, Jacobsen E. Follicular lymphoma: 2020 update on diagnosis and management. Am J Hematol 2020;95:316-327.Link BK, Maurer MJ, Nowakowski GS, et al. Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University

More news about: Knight Therapeutics Inc.


Mar 17, 2026, 07:35 ET Knight Therapeutics Anuncia Aprovação de Indicação Adicional para MINJUVI® (tafasitamabe) no Brasil

2012;157:188-196.Freedman A, Jacobsen E. Follicular lymphoma: 2020 update on diagnosis and management. Am J Hematol 2020;95:316-327.Link BK, Maurer MJ, Nowakowski GS, et al. Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University

More news about: Knight Therapeutics Inc.


Mar 17, 2026, 07:35 ET Knight Therapeutics anuncia la aprobación de una indicación adicional para MINJUVI® (tafasitamab) en Brasil

2012;157:188-196.Freedman A, Jacobsen E. Follicular lymphoma: 2020 update on diagnosis and management. Am J Hematol 2020;95:316-327.Link BK, Maurer MJ, Nowakowski GS, et al. Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University

More news about: Knight Therapeutics Inc.


Mar 12, 2026, 23:00 ET Sekisui Specialty Chemicals Announces Global Price Increase

innovation, bringing new functionality to the long trusted Selvol product line. The company also represents Advancell expandable microspheres and S-LEC BK polyvinyl acetal resins. Sekisui Specialty Chemicals is a subsidiary of the Sekisui Chemical Group, a multibillion-dollar, global company that delivers

More news about: Sekisui Specialty Chemicals


Mar 12, 2026, 23:00 ET Sekisui Specialty Chemicals Announces Global Price Increase

innovation, bringing new functionality to the long trusted Selvol product line. The company also represents Advancell expandable microspheres and S-LEC BK polyvinyl acetal resins. Sekisui Specialty Chemicals is a subsidiary of the Sekisui Chemical Group, a multibillion-dollar, global company that delivers

More news about: Sekisui Specialty Chemicals


Mar 11, 2026, 11:18 ET RiseLink Redefines Edge AI with the BK7259 "Powerhouse" and R2 Unified AI Developer Platform at Embedded World 2026

connectivity with a 20-year legacy in semiconductor innovation, today announced the launch of its BK7259 Edge AI powerhouse at Embedded World 2026. As the centerpiece of the new R2 Unified AI Developer Platform, the BK7259 is designed to move intelligence from the cloud directly onto hardware, enabling a

More news about: Riselink


Mar 11, 2026, 07:00 ET BIMZELX®▼(bimekizumab) superior to SKYRIZI® (risankizumab) in BE BOLD: first head-to-head study in active psoriatic arthritis (PsA) to demonstrate superiority in ACR50

https://www.ucb-usa.com/Innovation/Products/BIMZELX. Last accessed: March 2026.  GL-BK-2600024Date of preparation: March 2026© UCB Biopharma SRL, 2026. All rights reserved.

More news about: UCB


Mar 09, 2026, 12:00 ET Bloomberg Tax Showcases Industry-Leading AI-Powered Tools at TEI Midyear 2026

https://aboutbtax.com/bk2Y.About Bloomberg Tax Bloomberg Tax delivers a comprehensive suite of solutions designed to help tax and accounting

More news about: Bloomberg Tax


Mar 03, 2026, 01:57 ET Viraj Profiles Hosts 'Indradhanush of the Soul', Celebrating the International Appreciation of Indian Heritage

MLA, Palghar Vidhan Sabha, Shri Rajendra Gavit, along with the Kochhar family and senior leadership of Viraj Profiles.In a special moment, BK Santosh Didi (Santosh Kukreja) warmly welcomed Mr.

More news about: Viraj Profiles Pvt. Ltd.


Mar 02, 2026, 12:00 ET Bloomberg Law to Highlight Future-Ready Legal Solutions at Legalweek 2026

https://aboutblaw.com/bk23.About Bloomberg Law Bloomberg Law provides the content and technology legal professionals need to act decisively

More news about: Bloomberg Law


Mar 02, 2026, 08:30 ET Spinogenix Announces FRAXA Research Foundation Support for PIs Leading Phase 2b Trial of Investigational Therapy SPG601 for People with Fragile X Syndrome (FXS)

Phase 3 trial. FRAXA's early preclinical support helped establish the calcium-activated potassium ("BK") channel modulator mechanism behind SPG601. FRAXA also supported the development of another BK channel modulator, KER-0193, which released Phase 1 results last year and was acquired by Servier from

More news about: Spinogenix


Feb 26, 2026, 16:29 ET BNY Announces Pricing of Public Offering of $500,000,000 of Depositary Shares Representing Interests in Preferred Stock

NEW YORK, Feb. 26, 2026 /PRNewswire/ -- The Bank of New York Mellon Corporation ("BNY") (NYSE: BK), a global financial services company, today announced that it priced an underwritten public offering of 500,000 depositary shares, each representing

More news about: BNY


Feb 26, 2026, 16:07 ET Burger King Elevates Its Most Iconic Product, The Whopper®!

initiative inviting Guests to call or text President Tom Curtis. Guests have already helped shape operations, restaurant image and the overall BK experience and now, they've inspired changes to the iconic, flame-grilled Whopper sandwich – the first in nearly 10 years.

More news about: Burger King


Feb 26, 2026, 08:55 ET NYSE Content Update: 'Patty' at Center of Burger King's New BK Assistant AI Solution

reported earnings after the close on Wednesday, beating estimates on the top and bottom lines.Burker King has unveiled its AI-powered BK assistant solution, which aims to deliver real-time, voice-enabled intelligence to restaurant teams.Lumen Technologies (NYSE: LUMN) CEO

More news about: New York Stock Exchange


Feb 26, 2026, 08:00 ET RBI Reaffirms Growth Algorithm, including 8%+ Organic Adjusted Operating Income Growth and 5%+ Net Restaurant Growth by 2028, with Plans to Return $1.6 Billion of Capital to Shareholders in 2026

King sees meaningful opportunity to win with families and kids, who represent just 10% of the brand's traffic today.The Company also introduced BK Assistant, an AI-powered tool designed to streamline restaurant operations by providing managers and team members with instant access to operational

More news about: Restaurant Brands International Inc.


Feb 26, 2026, 08:00 ET RBI Reaffirms Growth Algorithm, including 8%+ Organic Adjusted Operating Income Growth and 5%+ Net Restaurant Growth by 2028, with Plans to Return $1.6 Billion of Capital to Shareholders in 2026

King sees meaningful opportunity to win with families and kids, who represent just 10% of the brand's traffic today.The Company also introduced BK Assistant, an AI-powered tool designed to streamline restaurant operations by providing managers and team members with instant access to operational

More news about: Restaurant Brands International Inc.


Feb 26, 2026, 08:00 ET Orsini Now Distributing Gene Therapies LYFGENIA™, ZYNTEGLO™, SKYSONA™

patients after SKYSONA infusion. Important opportunistic infections that have been diagnosed within the first 3 months after treatment with SKYSONA include BK cystitis, cytomegalovirus reactivation, human herpesvirus-6 viremia, candidiasis, and bacteremias. Opportunistic infections after the first 3 months

More news about: Orsini


Feb 26, 2026, 06:30 ET Lilly's oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet

Sun B, Yoshino H, Feng D, Suzuki Y, Fukazawa M, Nagao S, Wainscott DB, Showalter AD, Droz BA, Kobilka TS, Coghlan MP, Willard FS, Kawabe Y, Kobilka BK, & Sloop KW, Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist, Proc. Natl. Acad. Sci.

More news about: Eli Lilly and Company


Feb 25, 2026, 08:41 ET JBNU Researchers Review Advances in Pyrochlore Oxide-Based Dielectric Energy Storage Technology

Professor Chang Kyu Jeong from the Division of Advanced Materials Engineering, the Department of Energy Storage/Conversion Engineering of Graduate School (BK21 FOUR) & Hydrogen and Fuel Cell Research Center, and the Department of JBNU-KIST Industry-Academia Convergence Research, all at Jeonbuk National

More news about: JBNU


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.